期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | ORAL ONCOLOGY LetPub Score 7.7
51 ratings
Rate
Reputation 8.7 Influence 6.5 Speed 9.6 | ||||||||||||||||||||||||
期刊簡稱 | ORAL ONCOL | ||||||||||||||||||||||||
ISSN | 1368-8375 | ||||||||||||||||||||||||
E-ISSN | 1879-0593 | ||||||||||||||||||||||||
h-index | 101 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 5.00%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://www.journals.elsevier.com/oral-oncology/ | ||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/OO | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Elsevier Ltd | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||
創刊年 | 1997 | ||||||||||||||||||||||||
每年文章數 | 158每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 18.63% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1368-8375%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 3 Month(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 25% | ||||||||||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 5 Week(s) | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 下一頁 末頁 (頁 | |
[ORAL ONCOLOGY] 的評論 | 撰寫評論 |
作者: chairdu 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-08-26 11:18:16 評論於 It's like meeting two angel reviewers, there are no big problems, they have a deep understanding of our research ideas, and their questions are relatively simple.(0) 讚! | chairdu |
作者: Accept 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-21 17:01:57 評論於 The choice of ordering mode has no impact. Are you two reviewers?(0) 讚! | Accept |
作者: Accept 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-21 17:01:24 評論於 After the submission, one reviewer directly DIPed, I don't know if it was a direct rejection.(0) 讚! | Accept |
作者: chairdu 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-08-19 22:51:54 評論於 Submitted on 29th June 2024, minor revisions in about a month, ready for resubmission on 13th August. Choosing gold open access costs $4510, with a subscription option available. Not sure if choosing this option will have any impact.(0) 讚! | chairdu |
作者: 北风赤奋若 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-05 08:21:49 評論於 This seems to be a sister publication, I wonder what the quality is like(0) 讚! | 北风赤奋若 |
作者: 蠢小葱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-13 11:18:26 評論於 2024.02.13 Submitted to Journal 2024.02.13 Reject(0) 讚! | 蠢小葱 |
作者: 平乐mio 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-31 21:45:15 評論於 Do you need three copies of this picture?(0) 讚! | 平乐mio |
作者: 平乐mio 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-31 10:18:32 評論於 Do you need three repeated results? :Do you want three repeated results? :Do you require three repeated results?(0) 讚! | 平乐mio |
作者: 应龙司卿 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-17 08:01:13 評論於 Could you please share the citation format for endnotes? Thank you(0) 讚! | 应龙司卿 |
作者: 混元新曦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-25 11:08:12 評論於 Not worth investing in, it's just a letter(0) 讚! | 混元新曦 |
作者: 一只海桃呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-09 23:22:44 評論於 Review speed: 1.0 | Submission hit rate: 25.0 Experience sharing: Hey, newbie here! I want to ask if it's worth it to convert the submission into a letter. Any thoughts on how letters are received?(0) 讚! | 一只海桃呀 |
作者: 金顶念蕾 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-07 22:01:35 評論於 10.4 Status Update: Still Under Review(0) 讚! | 金顶念蕾 |
作者: Constance Adelaide 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-02 12:55:50 評論於 Looking forward to your updates. My situation is exactly the same as yours(0) 讚! | Constance Adelaide |
作者: 金顶念蕾 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-19 17:12:06 評論於 Just now 9.19 Under review(0) 讚! | 金顶念蕾 |
作者: 北陆皓洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-18 17:25:00 評論於 Have you received any requests to submit oral oncology reports? It seems that this journal does not have an impact factor(0) 讚! | 北陆皓洁 |
作者: 金顶念蕾 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-16 10:58:50 評論於 The previous submission of the radiation therapy green paper was rejected, but after external review of the green paper, some suggestions were given. The paper was revised according to the suggestions and resubmitted to oral oncology on September 12, 2023. As of September 13, the status is "with editor." On September 18, it is still "with editor," but a new deadline was given. Hopefully, good luck will come(0) 讚! | 金顶念蕾 |
作者: May Mathilda 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-12 08:46:06 評論於 Before two reviewers, the first reviewer praised and accepted the manuscript with a few comments. The second reviewer raised four major questions, one of which was to supplement smoking history, PS score, and pathological type data; also to provide a table of non-chemotherapy regimens and kappa values; and finally, made about 30 other minor and major suggestions including grammar, content details, etc. All suggestions were addressed as requested. The manuscript was eventually accepted on August 11th. The first submission to a non-water journal ?(0) 讚! | May Mathilda |
作者: May Mathilda 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-30 21:31:49 評論於 7-26 received revised version with two reviewers. The first reviewer provided no suggestions, recommending acceptance directly. The second reviewer raised over 30 questions, all of which were addressed in the response. The manuscript was resubmitted on 7-30, hoping for acceptance (as the first article in the forthcoming non-water-related issue(0) 讚! | May Mathilda |
作者: May Mathilda 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-23 16:36:47 評論於 Research focus: Head and neck tumors; Tumor experience sharing: Previously submitted for publication, rejected, then submitted to this journal on July 6, contacted by editor on July 7, under review as of July 13, sent to 2+ reviewers, with two reviewers agreeing to review, first reviewer completed on July 17, second reviewer completed on July 25, currently in the "required reviews completed" status, hoping for a positive outcome(0) 讚! | May Mathilda |
作者: Avery Gunther 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-03 10:45:49 評論於 Is there any news now?(0) 讚! | Avery Gunther |
作者: 重阳水曼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-05 12:42:10 評論於 I don't know what's going on either(0) 讚! | 重阳水曼 |
作者: 玄冰玉环 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-29 20:41:27 評論於 Review speed: 1.0 | Submission success rate: 50.0 Sharing experience: The acceptance rate of self-introduction on the OO official website is 22%, which is not as high as introduced here. Another issue is that I found that the ratio of articles to letters in each issue is at least 1:1.5, or even close to 1:2. If the 22% includes letters, then the acceptance rate of articles is less than 10%, and many submissions are articles while editors request letters. Mainland Chinese articles account for slightly more than 20%, estimating approximately 40-50 articles published in China each year, naturally including letters, seem not as difficult as imagined(0) 讚! | 玄冰玉环 |
作者: 太山天震 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-18 18:33:25 評論於 Is there a response now?(0) 讚! | 太山天震 |
作者: 仙灵安白 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-08 22:39:17 評論於 Review speed: 2.0 | Submission hit rate: 25.0 Emphasized research direction: Oral tumor Experience sharing: It's been a month with the editor and still no response. I've followed up once, not sure how long it will take(0) 讚! | 仙灵安白 |
作者: 冷桃小哥哥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-22 19:09:18 評論於 Well, it's been 4 days with no changes. Does that mean the results aren't good? ?(0) 讚! | 冷桃小哥哥 |
首頁 上一頁 1 2 3 4 下一頁 末頁 (頁 |
Contact us